|
|
|
|
LEADER |
01558nam a2200313 u 4500 |
001 |
EB001892071 |
003 |
EBX01000000000000001055218 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
200301 r ||| eng |
100 |
1 |
|
|a Herington, Elijah
|
245 |
0 |
0 |
|a Non-invasive fetal RHD genotyping
|h Elektronische Ressource
|b a rapid qualitative review
|c Elijah Herington, Hannah Loshak
|
250 |
|
|
|a Version 1.0
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2019, June 27, 2019
|
300 |
|
|
|a 1 PDF file (14 pages)
|b illustration
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Noninvasive Prenatal Testing
|
653 |
|
|
|a Rh-Hr Blood-Group System / genetics
|
653 |
|
|
|a Qualitative Research
|
653 |
|
|
|a Genotyping Techniques
|
653 |
|
|
|a Erythroblastosis, Fetal / prevention & control
|
700 |
1 |
|
|a Loshak, Hannah
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK546039
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a Non-invasive fetal RhD blood group genotyping, also known as fetal RhD genotyping, is meant to identify Rh compatibility between pregnant persons and their fetus. It offers the potential to avoid unnecessary prenatal treatment or other invasive forms of fetal blood group identification
|